MAY 21 3PostersMonday AfternoonMorningNeural Hormonal Mechanisms (Renin;Neural Control; Vasoactive Autacoids)PO-298: 1PO-299: 1PO-300: 2Correlation of Neuropeptide Y (NPY) Serrum Levels<strong>and</strong> Ankle Branchial Index (ABI) as an Index ofAtherosclerosisMaria Baltatzi, 1 Christos Savopoulos, 1 KonstantinosTziomalos, 1 Niki Katsiki, 1 George Koliakos, 2 ApostolosHatzitolios†. 1 1 1st Propedeutic Medical Department,AXEPA Hospital, Aristotles University of Thessaloniki,Thessaloniki, GR <strong>and</strong> 2 Department of BiologicalChemistry, Aristotles University of Thessaloniki,Thessaloniki, GR.Cerebrovascular Evaluation with TranscranialDoppler in Patients with Neuro-Mediated Syncope.Is Autoregulation Impaired?Joao P. Freitas, 1 Elsa Azevedo, 2 Rosa M. Santos, 2Pedro Castro, 1 Maria Julia Maciel, 2 FranciscoRocha Goncalves. 2 1 Centro de Estudos da FuncaoAutonomica, Hospital de Sao Joao, Porto, PT <strong>and</strong>2 Faculdade de Medicina do Porto, Porto, PT.Aldosterone/Renin Ratio is a Predictor ofCardiovascular Events in Patients with EssentialHypertensionTomohiko Kisaka, Ryoji Ozono, Yasuki Kihara.Department of Cardiovascular Medicine, HiroshimaUniversity Graduate School of Biomedical Science,Hiroshima, JP.ObesityPO-301: 1PO-302: 1Aldosterone Breakthrough Despite ACE Inhibitorsor ARBS in Overweight/Obese HypertensivePatients: Body Mass Index as a Predictor of PlasmaAldosterone LevelsRiccardo Sarzani, Federico Guerra, Lucia Mancinelli,Laura Roberti, Marica Bordicchia, Paolo LorenzoDessì-Fulgheri, Aless<strong>and</strong>ro Rappelli. Dept. InternalMedicine, University Ancona - Politecnica Marche,Ancona, IT.Vitamin D Deficiency Blunts Vascular Sensitivity toAngiotensin II in ObesityAn<strong>and</strong> Vaidya, 1 John P. Forman, 2 Naomi D. Fisher, 1Jonathan S. Williams. 1 1 Brigham <strong>and</strong> Women’sHospital: Division of Endocrinology, Diabetes, <strong>and</strong>Hypertension, Boston, US <strong>and</strong> 2 Brigham <strong>and</strong> Women’sHospital: Channing Laboratory Renal Division, US.1 Pathobiology Track 2 Translational Track 3 Therapy Track154
Monday Morning Afternoon MAY 21 3PostersPO-303: 3PO-304: 3PO-305: 3PO-306: 2Antihypertensive Efficacy of Amlodipine/Valsartan/Hydrochlorothiazide Triple Combination in Patientswith Obesity: A Subgroup AnalysisDavid A. Calhoun†, 1 Yves Lacourciere, 2 Nora A.Crikelair, 3 Joseph Yen, 3 Robert Glazer. 3 1 VascularBiology <strong>and</strong> Hypertension Program, University ofAlabama at Birmingham, Birmingham, AL, US;2 Hypertension Research Unit, Centre Hospitalier del’Université Laval, Ste-Foy, Quebec, CA <strong>and</strong> 3 NovartisPharmaceuticals Corporation, East Hanover, NJ, US.Anthropometric Predictors of Left VentricularHypertrophy in Hypertensive WomenBranko Jakovljevic†, 1 Vesna Stojanov, 2 Dragan Lovic, 3Katarina Paunovic, 1 Goran Belojevic. 1 1 Institute ofHygiene <strong>and</strong> Medical Ecology, School of Medicine,Belgrade, YU; 2 Clinical Centre of Serbia, Belgrade, YU<strong>and</strong> 3 Private Internal Medicine Clinic “Lovic”, Nis, YU.Effect of High-Fat Diet on Oxidative Stress <strong>and</strong>Metabolic Syndrome in C57BI/mice <strong>and</strong> PreventiveEffect of Antioxidant SupplementationHilda Vargas-Robles, 1 Monica Arellano-Mendoza, 2Ana Gamez-Mendez, 1 Amelia Rios, 3 Bruno Escalante. 31 CINVESTAV-IPN, Distrito Federal, MX; 2 EscuelaSuperior de Medcina, Distrito Federal, MX <strong>and</strong>3 CINVESTAV-IPN, Apodaca, Nuevo Leon, MX.The Role of Obesity Variables in DetectingHypertension in an Iranian PopulationPatricia Khashayar, Hamid Reza Aghaei Meybodi,Mohsen Rezai Homami, Mohammad RezaMohajeri Tehrani, Ramin Heshmat, Bagher Larijani.Endocrinology & Metabolism Research Center(EMRC), Tehran, IR.Pediatric HypertensionPO-307: 1PO-308: 1Brachyal Pulsatility Index in Treated AorticCoarctationAntonio J. Marinho-da-Silva, 1 Dina T. Rodrigues, 2Helena M. Andrade, 3 Guilherme M. Pêgo, 4 Luis A.Providência. 5 1 University Hospital, Coimbra, PT;2 University Hospital, PT; 3 University Hospital, PT;4 University Hospital, PT <strong>and</strong> 5 University Hospital, PT.Presence of Target Organ Damage in Pre-Hypertensive YouthElaine Urbina†, 1 Philip Khoury, 1 Connie McCoy, 1Stephen Daniels, 2 Thomas Kimball, 1 Larry Dolan. 11 Cincinnati Children’s Hosp, Cincinnati, OH, US <strong>and</strong>2 Children’s Hosp, Aurora, CO, US.1 Pathobiology Track 2 Translational Track 3 Therapy Track155
- Page 1 and 2:
American Society of Hypertension201
- Page 3 and 4:
Valturna offers bothsuperior BP eff
- Page 5 and 6:
Figure 2: Probability of Achieving
- Page 7 and 8:
potential for other drugs acting on
- Page 9 and 10:
aliskiren arms were about one-third
- Page 11 and 12:
As with other drugs that block angi
- Page 13:
American Society of Hypertension201
- Page 18:
Program Color KeyThe pages of this
- Page 21 and 22:
General InformationThis program boo
- Page 23 and 24:
General Information continuedHilton
- Page 25 and 26:
General Information continuedASH Sc
- Page 27 and 28:
General Information continuedASH Hy
- Page 29 and 30:
2010 ASH Corporate MembersBoehringe
- Page 31 and 32:
ASH Leadership2009-2010 Board of Di
- Page 33 and 34:
Special LectureMonday, May 3, 2010,
- Page 35 and 36:
Special LectureMonday, May 3, 2010,
- Page 37 and 38:
2010 Abstract Reviewers continuedEr
- Page 39 and 40:
Visit TEKTURNA at Booth 1100.and/or
- Page 41 and 42:
5.5 HyperkalemiaIncreases in serum
- Page 43 and 44:
with Pgp substrates or weak to mode
- Page 45 and 46:
ASH Program at a GlanceSaturday, Ma
- Page 47 and 48:
ASH Program at a GlanceMonday, May
- Page 49 and 50:
Poster Category PresentationPosters
- Page 51 and 52:
2010 ASH Faculty continuedJeffrey R
- Page 53 and 54:
2010 ASH Faculty continuedAndrew Wh
- Page 55 and 56:
2010American Societyof Hypertension
- Page 57 and 58:
Saturday Afternoon MAY 1PostersPost
- Page 59 and 60:
Saturday Afternoon MAY 1Sessions3:3
- Page 61 and 62:
Saturday Afternoon MAY 1Sessions3:3
- Page 63 and 64:
Sunday Morning MAY 2Satellite Sympo
- Page 65 and 66:
Sunday Morning MAY 2Sessions contin
- Page 67 and 68:
Sunday Morning MAY 2Sessions8:00 AM
- Page 69 and 70:
Sunday Morning MAY 2Sessions10:00 A
- Page 71 and 72:
Sunday Morning MAY 2Sessions10:00 A
- Page 73 and 74:
Sunday Afternoon MAY 2Sessions3:30
- Page 75 and 76:
Sunday Afternoon MAY 2Sessions3:30
- Page 77 and 78:
Sunday Afternoon MAY 2Special Sessi
- Page 79 and 80:
Sunday Evening MAY 2Sessions6:00 PM
- Page 81 and 82:
Sunday Evening MAY 2Sessions6:00 PM
- Page 83 and 84:
Monday Morning MAY 3Satellite Sympo
- Page 85 and 86:
Monday Morning MAY 3Sessions8:00 AM
- Page 87 and 88:
Monday Morning Afternoon MAY 21 3Po
- Page 89 and 90:
Monday Morning MAY 3Sessions10:00 A
- Page 91 and 92:
Monday Morning MAY 3Sessions10:00 A
- Page 93 and 94:
Monday Morning MAY 3Sessions11:45 A
- Page 95 and 96:
Monday Evening May 3Satellite Sympo
- Page 97 and 98:
Tuesday Morning May 48:45 AM LB-OR-
- Page 99 and 100:
Tuesday Morning May 4Sessions8:00 A
- Page 101 and 102:
Tuesday Morning MAY 4ASH Membership
- Page 103 and 104:
Tuesday Morning MAY 4Sessions10:55
- Page 105 and 106: 2010American Societyof Hypertension
- Page 107 and 108: Saturday Afternoon MAY 1Posters3:00
- Page 109 and 110: Saturday Afternoon MAY 1PostersPO-2
- Page 111 and 112: Saturday Afternoon MAY 1PostersPO-3
- Page 113 and 114: Saturday Afternoon MAY 1PostersPO-4
- Page 115 and 116: Saturday Afternoon MAY 1PostersPO-5
- Page 117 and 118: Saturday Afternoon MAY 1PostersPO-7
- Page 119 and 120: Saturday Afternoon MAY 1PostersPO-8
- Page 121 and 122: Saturday Afternoon MAY 1PostersPO-9
- Page 123 and 124: Saturday Afternoon MAY 1PostersPO-1
- Page 125 and 126: Sunday Morning MAY 2PostersPosters
- Page 127 and 128: Sunday Morning MAY 2Posters9:00 AM
- Page 129 and 130: Sunday Morning MAY 2PostersPO-123:
- Page 131 and 132: Sunday Morning MAY 2PostersPO-137:
- Page 133 and 134: Sunday Morning MAY 2PostersPO-150:
- Page 135 and 136: Sunday Morning MAY 2PostersPO-163:
- Page 137 and 138: Sunday Morning MAY 2PostersPO-178:
- Page 139 and 140: Sunday Morning MAY 2PostersPO-193:
- Page 141 and 142: Sunday Morning MAY 2PostersPO-206:
- Page 143 and 144: Monday Morning Afternoon MAY 21 3Po
- Page 145 and 146: Monday Morning Afternoon MAY 21 3Po
- Page 147 and 148: Monday Morning Afternoon MAY 21 3Po
- Page 149 and 150: Monday Morning Afternoon MAY 21 3Po
- Page 151 and 152: Monday Morning Afternoon MAY 21 3Po
- Page 153 and 154: Monday Morning Afternoon MAY 21 3Po
- Page 155: Monday Morning Afternoon MAY 21 3Po
- Page 159 and 160: Monday Morning Afternoon MAY 21 3Po
- Page 161 and 162: Monday Morning Afternoon May 213Pos
- Page 163 and 164: Faculty Disclosure ListingGail Adle
- Page 165 and 166: Faculty Disclosure Listing continue
- Page 167 and 168: Faculty Disclosure Listing continue
- Page 169 and 170: Faculty Disclosure Listing continue
- Page 171 and 172: Faculty Disclosure Listing continue
- Page 173 and 174: you to attend thethe Innovations Th
- Page 175 and 176: 5.5 HyperkalemiaIncreases in serum
- Page 177 and 178: with Pgp substrates or weak to mode
- Page 179 and 180: Valturna (aliskiren and valsartan,
- Page 181 and 182: 4 CONTRAINDICATIONSNone.5 WARNINGS
- Page 183 and 184: een reported. In a 4-day trial of v
- Page 185 and 186: 7 DRUG INTERACTIONSNo drug interact
- Page 187 and 188: 8.5 Geriatric UseIn 8.5the Geriatri
- Page 189 and 190: 2010 ASH ExhibitorsASH Hypertension
- Page 191 and 192: ASH Hypertension Resource CenterHil
- Page 193 and 194: 2010 ASH Exhibitors continuedCVRx I
- Page 195 and 196: 2010 ASH Exhibitors continuedIntern
- Page 197 and 198: 2010 ASH Exhibitors continuedNature
- Page 199 and 200: 2010 ASH Exhibitors continuedRESPeR
- Page 201 and 202: Author IndexAAbaunza, Ricardo, 122A
- Page 203 and 204: Author IndexCastellano, Maurizio, 1
- Page 205 and 206: Author IndexGuarneri, Marco, 146Guo
- Page 207 and 208:
Author IndexLekakis, John, 118, 122
- Page 209 and 210:
Author IndexPittaras, Andreas, 149P
- Page 211 and 212:
Author IndexTello, Susana, 109, 135
- Page 213 and 214:
Hilton New York Floor PlansSecond F
- Page 215 and 216:
Hilton New York Floor PlansFourth F
- Page 218:
Are You 1in 3?Get the facts. Know y